| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Oct 23, 2025 | Oct 27, 2025 | Viridian Therapeutics, Inc.\DE | Director | Buy | 100.0 | +454,545 | 13.14% | ✗ | $10M |
| Sep 13, 2024 | Sep 17, 2024 | Viridian Therapeutics, Inc.\DE | Director | Buy | 100.0 | +1,600,000 | 86.68% | ✗ | $30M |
| Jan 22, 2024 | Jan 24, 2024 | Viridian Therapeutics, Inc.\DE | Director | Buy | 100.0 | +476,190 | 34.77% | ✗ | $10M |
| Aug 17, 2022 | Aug 19, 2022 | Viridian Therapeutics, Inc.\DE | Director | Buy | 100.0 | +425,531 | 45.07% | ✗ | $10M |
| Sep 21, 2021 | Sep 23, 2021 | Viridian Therapeutics, Inc.\DE | Director | Buy | 100.0 | +909,000 | 2590.33% | ✗ | $10M |